The Medical Research Future Fund (MRFF) – Emerging Priorities and Consumer Driven Research Initiative - 2020 Improving Diagnosis in Cancers with Low Survival Rates Grant Opportunity aims to improve the health and wellbeing of Australians by supporting research that improves the five-year relative survival rate for ovarian cancer, cancers of the pancreas, liver cancer, lung cancer and cancers with unknown primary site by enabling early diagnosis.
Applications to this grant opportunity must propose research that addresses one of the two Streams of research:
- Stream 1: utilise existing evidence to develop or improve approaches for the early diagnosis of ovarian cancer, cancers of the pancreas, liver cancer or lung cancer that have a clinically feasible pathway to implementation
- Stream 2: enable approaches for the early diagnosis of cancers with unknown primary site that have a clinically feasible pathway to implementation.
This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health.
Further information on the Medical Research Future Fund (MRFF) is available from the Department of Health’s MRFF website.